{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:41:59Z","timestamp":1792172519997,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Center for Big Data Analytics and Statistics at Chang Gung Memorial Hospital, Linkou, and the Chang Gung Research Database","award":["CGRPG3M0021"],"award-info":[{"award-number":["CGRPG3M0021"]}]},{"name":"Center for Big Data Analytics and Statistics at Chang Gung Memorial Hospital, Linkou, and the Chang Gung Research Database","award":["CGRPG3M0041"],"award-info":[{"award-number":["CGRPG3M0041"]}]},{"name":"Center for Big Data Analytics and Statistics at Chang Gung Memorial Hospital, Linkou, and the Chang Gung Research Database","award":["CGRPG3N0061"],"award-info":[{"award-number":["CGRPG3N0061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10067-025-07562-1","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:44:08Z","timestamp":1752554648000},"page":"3605-3613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Coexistence of anti-melanoma differentiation-associated protein 5 and anti-Ro52 antibodies in patients with idiopathic inflammatory myopathy: a retrospective cohort study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6441-5990","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0753-4529","authenticated-orcid":false,"given":"Tien-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"issue":"1","key":"7562_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, Mchugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280(1):8\u201323. https:\/\/doi.org\/10.1111\/joim.12451","journal-title":"J Intern Med"},{"issue":"5","key":"7562_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ Mchugh","year":"2018","unstructured":"Mchugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14(5):290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","journal-title":"Nat Rev Rheumatol"},{"key":"7562_CR3","doi-asserted-by":"publisher","first-page":"152088","DOI":"10.1016\/j.semarthrit.2022.152088","volume":"57","author":"A Teel","year":"2022","unstructured":"Teel A, Lu J, Park J, Singh N, Basharat P (2022) The role of myositis-specific autoantibodies and the management of interstitial lung disease in idiopathic inflammatory myopathies: a systematic review. Semin Arthritis Rheum 57:152088. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152088","journal-title":"Semin Arthritis Rheum"},{"key":"7562_CR4","doi-asserted-by":"publisher","first-page":"9141420","DOI":"10.1155\/2019\/9141420","volume":"2019","author":"C Cassius","year":"2019","unstructured":"Cassius C, Le Buanec H, Bouaziz JD, Amode R (2019) Biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome. J Immunol Res 2019:9141420. https:\/\/doi.org\/10.1155\/2019\/9141420","journal-title":"J Immunol Res"},{"issue":"5","key":"7562_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571\u20131576. https:\/\/doi.org\/10.1002\/art.21023","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7562_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","volume":"41","author":"P Mehta","year":"2021","unstructured":"Mehta P, Machado PM, Gupta L (2021) Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatol Int 41(6):1021\u20131036. https:\/\/doi.org\/10.1007\/s00296-021-04819-1","journal-title":"Rheumatol Int"},{"issue":"3","key":"7562_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y et al (2020) Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol 72(3):488\u2013498. https:\/\/doi.org\/10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"key":"7562_CR8","doi-asserted-by":"publisher","first-page":"152231","DOI":"10.1016\/j.semarthrit.2023.152231","volume":"62","author":"H Xie","year":"2023","unstructured":"Xie H, Zhang D, Wang Y et al (2023) Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: a meta-analysis and systematic review. Semin Arthritis Rheum 62:152231. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152231","journal-title":"Semin Arthritis Rheum"},{"key":"7562_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2021.04.020","volume":"91","author":"P Decker","year":"2021","unstructured":"Decker P, Moulinet T, Lopez B et al (2021) Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases. Eur J Intern Med 91:45\u201352. https:\/\/doi.org\/10.1016\/j.ejim.2021.04.020","journal-title":"Eur J Intern Med"},{"key":"7562_CR10","doi-asserted-by":"publisher","first-page":"1068402","DOI":"10.3389\/fmed.2023.1068402","volume":"10","author":"A Ceribelli","year":"2023","unstructured":"Ceribelli A, Tonutti A, Isailovic N, De Santis M, Selmi C (2023) Interstitial lung disease associated with inflammatory myositis: autoantibodies, clinical phenotypes, and progressive fibrosis. Front Med 10:1068402. https:\/\/doi.org\/10.3389\/fmed.2023.1068402","journal-title":"Front Med"},{"issue":"7","key":"7562_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","volume":"8","author":"J Schulte-Pelkum","year":"2009","unstructured":"Schulte-Pelkum J, Fritzler M, Mahler M (2009) Latest update on the Ro\/SS-A autoantibody system. Autoimmun Rev 8(7):632\u2013637. https:\/\/doi.org\/10.1016\/j.autrev.2009.02.010","journal-title":"Autoimmun Rev"},{"key":"7562_CR12","doi-asserted-by":"publisher","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","volume":"12","author":"A Nombel","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 Antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol 12:773352. https:\/\/doi.org\/10.3389\/fimmu.2021.773352","journal-title":"Front Immunol"},{"issue":"2","key":"7562_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.221067","volume":"50","author":"NJ Mchugh","year":"2023","unstructured":"Mchugh NJ (2023) Ro52, Myositis, and interstitial lung disease. J Rheumatol 50(2):161\u2013163. https:\/\/doi.org\/10.3899\/jrheum.221067","journal-title":"J Rheumatol"},{"issue":"2","key":"7562_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12016-021-08911-z","volume":"63","author":"EKL Chan","year":"2022","unstructured":"Chan EKL (2022) Anti-ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis. Clin Rev Allergy Immunol 63(2):178\u2013193. https:\/\/doi.org\/10.1007\/s12016-021-08911-z","journal-title":"Clin Rev Allergy Immunol"},{"issue":"14","key":"7562_CR15","doi-asserted-by":"publisher","first-page":"e00321-18","DOI":"10.1128\/JVI.00321-18","volume":"92","author":"B Xue","year":"2018","unstructured":"Xue B, Li H, Guo M et al (2018) TRIM21 promotes innate immune response to rna viral infection through lys27-linked polyubiquitination of MAVS. J Virol 92(14):e00321-18. https:\/\/doi.org\/10.1128\/JVI.00321-18","journal-title":"J Virol"},{"issue":"2","key":"7562_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3899\/jrheum.220139","volume":"50","author":"C Lv","year":"2023","unstructured":"Lv C, You H, Xu L et al (2023) Coexistence of anti-ro52 antibodies in anti-MDA5 antibody-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk. J Rheumatol 50(2):219\u2013226. https:\/\/doi.org\/10.3899\/jrheum.220139","journal-title":"J Rheumatol"},{"key":"7562_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roae052","author":"T Sugita","year":"2024","unstructured":"Sugita T, Tsuboi H, Sugita N et al (2024) Clinical importance of anti-Ro52 antibody for polymyositis and dermatomyositis. Mod Rheumatol. https:\/\/doi.org\/10.1093\/mr\/roae052","journal-title":"Mod Rheumatol"},{"issue":"7","key":"7562_CR18","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1093\/rheumatology\/keaa786","volume":"60","author":"A Xu","year":"2021","unstructured":"Xu A, Ye Y, Fu Q et al (2021) Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease. Rheumatology (Oxford) 60(7):3343\u20133351. https:\/\/doi.org\/10.1093\/rheumatology\/keaa786","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"7562_CR19","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M et al (2017) 2017 European league against rheumatism\/american college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69(12):2271\u20132282. https:\/\/doi.org\/10.1002\/art.40320","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"7562_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347. https:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"7562_CR21","doi-asserted-by":"publisher","unstructured":"Bradley B, Branley HM, Egan JJ, et al. (2008) Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society. Thorax 63 Suppl 5(v1\u201358. https:\/\/doi.org\/10.1136\/thx.2008.101691","DOI":"10.1136\/thx.2008.101691"},{"issue":"20","key":"7562_CR22","doi-asserted-by":"publisher","first-page":"e15578","DOI":"10.1097\/MD.0000000000015578","volume":"98","author":"J Temmoku","year":"2019","unstructured":"Temmoku J, Sato S, Fujita Y et al (2019) Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis\/dermatomyositis. Medicine (Baltimore) 98(20):e15578. https:\/\/doi.org\/10.1097\/MD.0000000000015578","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7562_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-021-01705-8","volume":"16","author":"Q Yang","year":"2021","unstructured":"Yang Q, Li T, Zhang X et al (2021) Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients. Orphanet J Rare Dis 16(1):58. https:\/\/doi.org\/10.1186\/s13023-021-01705-8","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"7562_CR24","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s10067-022-06291-z","volume":"41","author":"L Wen","year":"2022","unstructured":"Wen L, Chen X, Cheng Q et al (2022) Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China. Clin Rheumatol 41(11):3419\u20133427. https:\/\/doi.org\/10.1007\/s10067-022-06291-z","journal-title":"Clin Rheumatol"},{"issue":"11","key":"7562_CR25","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","volume":"61","author":"X Gui","year":"2022","unstructured":"Gui X, Shenyun S, Ding H et al (2022) Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease. Rheumatology (Oxford) 61(11):4570\u20134578. https:\/\/doi.org\/10.1093\/rheumatology\/keac090","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"7562_CR26","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H et al (2017) Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol 44(7):1051\u20131057. https:\/\/doi.org\/10.3899\/jrheum.161480","journal-title":"J Rheumatol"},{"key":"7562_CR27","doi-asserted-by":"publisher","first-page":"104804","DOI":"10.1016\/j.ebiom.2023.104804","volume":"96","author":"V Leclair","year":"2023","unstructured":"Leclair V, Galindo-Feria AS, Rothwell S et al (2023) Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies. EBioMedicine 96:104804. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104804","journal-title":"EBioMedicine"},{"issue":"1\u20132","key":"7562_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","volume":"39","author":"V Oke","year":"2012","unstructured":"Oke V, Wahren-Herlenius M (2012) The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J Autoimmun 39(1\u20132):77\u201382. https:\/\/doi.org\/10.1016\/j.jaut.2012.01.014","journal-title":"J Autoimmun"},{"issue":"3","key":"7562_CR29","doi-asserted-by":"publisher","first-page":"103013","DOI":"10.1016\/j.autrev.2021.103013","volume":"21","author":"P Decker","year":"2022","unstructured":"Decker P, Moulinet T, Pontille F et al (2022) An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev 21(3):103013. https:\/\/doi.org\/10.1016\/j.autrev.2021.103013","journal-title":"Autoimmun Rev"},{"key":"7562_CR30","doi-asserted-by":"publisher","first-page":"106134","DOI":"10.1016\/j.rmed.2020.106134","volume":"172","author":"X Xing","year":"2020","unstructured":"Xing X, Li A, Li C (2020) Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis. Respir Med 172:106134. https:\/\/doi.org\/10.1016\/j.rmed.2020.106134","journal-title":"Respir Med"},{"issue":"1","key":"7562_CR31","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1038\/s41598-023-30595-y","volume":"13","author":"P Zhou","year":"2023","unstructured":"Zhou P, Shen Q, Zhou S et al (2023) The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study. Sci Rep 13(1):3863. https:\/\/doi.org\/10.1038\/s41598-023-30595-y","journal-title":"Sci Rep"},{"issue":"1","key":"7562_CR32","doi-asserted-by":"publisher","first-page":"e002076","DOI":"10.1136\/bmjresp-2023-002076","volume":"10","author":"S Nayebirad","year":"2023","unstructured":"Nayebirad S, Mohamadi A, Yousefi-Koma H et al (2023) Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis. BMJ Open Respir Res 10(1):e002076. https:\/\/doi.org\/10.1136\/bmjresp-2023-002076","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"7562_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13075-024-03382-x","volume":"26","author":"CT Weng","year":"2024","unstructured":"Weng CT, Huang TH, Wu CH, Sun YT (2024) Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy. Arthritis Res Ther 26(1):152. https:\/\/doi.org\/10.1186\/s13075-024-03382-x","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"7562_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/mr\/road042","volume":"34","author":"B Yang","year":"2024","unstructured":"Yang B, Liu S, Qian Z, Tong Z (2024) Predicting the death of patients with anti-melanoma differentiation-associated protein-5-positive dermatomyositis-associated interstitial lung disease: a systematic review and meta-analysis. Mod Rheumatol 34(3):541\u2013550. https:\/\/doi.org\/10.1093\/mr\/road042","journal-title":"Mod Rheumatol"},{"issue":"5","key":"7562_CR35","doi-asserted-by":"publisher","first-page":"e0155381","DOI":"10.1371\/journal.pone.0155381","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu G, Gao D et al (2016) Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS ONE 11(5):e0155381. https:\/\/doi.org\/10.1371\/journal.pone.0155381","journal-title":"PLoS ONE"},{"issue":"7","key":"7562_CR36","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","volume":"57","author":"S Sato","year":"2018","unstructured":"Sato S, Masui K, Nishina N et al (2018) Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology (Oxford) 57(7):1212\u20131221. https:\/\/doi.org\/10.1093\/rheumatology\/key060","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7562_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Hu K, Cai X et al (2022) Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B 12(1):18\u201332. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.023","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"7562_CR38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10067-024-07093-1","volume":"43","author":"W Mo","year":"2024","unstructured":"Mo W, Xing X, Zhai S et al (2024) Anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis with liver dysfunction: a warning sign of higher death risk. Clin Rheumatol 43(11):3389\u20133397. https:\/\/doi.org\/10.1007\/s10067-024-07093-1","journal-title":"Clin Rheumatol"},{"issue":"3","key":"7562_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, Macmahon H et al (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246(3):697\u2013722. https:\/\/doi.org\/10.1148\/radiol.2462070712","journal-title":"Radiology"},{"key":"7562_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","volume":"121(91\u201399","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Fujisawa T, Nakashima R et al (2016) Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med 121(91\u201399:91. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.019","journal-title":"Respir Med"},{"issue":"1","key":"7562_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13023-023-02827-x","volume":"18","author":"L Liu","year":"2023","unstructured":"Liu L, Zhang Y, Wang C et al (2023) Ground-glass opacity score predicts the prognosis of anti-MDA5 positive dermatomyositis: a single-centre cohort study. Orphanet J Rare Dis 18(1):208. https:\/\/doi.org\/10.1186\/s13023-023-02827-x","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"7562_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s11604-021-01120-w","volume":"39","author":"D Cozzi","year":"2021","unstructured":"Cozzi D, Cavigli E, Moroni C et al (2021) Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol 39(8):721\u2013732. https:\/\/doi.org\/10.1007\/s11604-021-01120-w","journal-title":"Jpn J Radiol"},{"key":"7562_CR43","doi-asserted-by":"publisher","unstructured":"To F, Ventin-Rodriguez C, Elkhalifa S, Lilleker JB, and Chinoy H (2020) Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results. BMC Rheumatol 4(28).https:\/\/doi.org\/10.1186\/s41927-020-00132-9","DOI":"10.1186\/s41927-020-00132-9"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07562-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T07:49:54Z","timestamp":1756453794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["7562"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07562-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This retrospective study was approved by the institutional review board at the Division of Rheumatology, Allergy, and Immunology, Chang Gung Memorial Hospital, Taoyuan-Yuan, Taiwan. This retrospective study was approved by the Institutional Review Board (IRB) of Chang Gung Memorial Hospital (IRB No. 202101542B0C604). The requirement for obtaining informed consent was waived by the IRB as the study utilized pre-existing, anonymized data, posing minimal risk to the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}